Article

Overheard on Social Media: CURE Readers Discuss Survivorship Plans

Author(s):

CURE staff

We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.

Here's what our readers had to say about their survivorship plans!

social media cancer
Related Videos
Dr. Alan Tan is a genitourinary oncology (GU) and melanoma specialist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee; an associate professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center; and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Related Content
Illustration of blood cells.
March 14th 2025

Longer Imbruvica and Venclexta Treatment May Be Beneficial in R/R CLL

Alex Biese
For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found to be beneficial.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of woman with blonde hair.
March 13th 2025

Trusting My Stage 4 Breast Cancer Body

Martha Carlson
Practicing consistency has made a difference for me while living with stage 4 breast cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
The phase 2 TEDOPaM trial in pancreatic ductal adenocarcinoma met its primary end point. © Crystal_Light- stock.adobe.com.
March 12th 2025

Tedopi Cancer Vaccine Meets Trial End Point For Pancreatic Cancer

Ryan Scott
The phase 2 TEDOPaM trial evaluating patients with advanced or metastatic pancreatic ductal adenocarcinoma met its primary end point.
It’s easy to think of scientific researchers as existing in a vacuum. © Dr_Microbe - stock.adobe.com.
March 12th 2025

Bringing Together the CAR T-Cell Therapy Community

The Leukemia & Lymphoma Society
It’s easy to think of scientific researchers as existing in a vacuum.